Novel single-chain peptide mimetics of relaxin-2, B7-33, for the treatment of fibrosis

Fibrosis and related disorders are among the leading causes of death worldwide highlighting the need for more direct and improved anti-fibrotic strategies.

We have shown in animal models that H2 relaxin has therapeutic potential for fibrosis and related disorders. However, the H2 peptide has a complex insulin-like 2 chain structure with three disulphide bonds and short plasma half-life that makes the peptide expensive to manufacture and less effective as a long-term drug treatment. In a major breakthrough published in Chemical Science (flagship journal, Royal Society of Chemistry) we discovered a single-chain variant of H2 relaxin (B7-33) which has no disulfide bridges, and which is easy to manufacture and modify to improve its in vivo plasma half-life.

B7-33 was shown to specifically bind the relaxin receptor, RXFP1, and preferentially activate pathways related to anti-fibrotic effects in fibroblast in vitro and in rats and mouse models of fibrosis in vivo without side effects. Thus, B7-33 represents the first single-chain functionally-selective agonist of RXFP1. In this proposed study, we will unravel the pharmacological basis of functional selectivity of B7-33.

Additionally we will test if B7-33 is able to mimic other actions of H2 relaxin related to heart failure. We will further modify and optimise our current lead B7-33 by using rational structure-based drug design and medicinal chemistry techniques (stapling, lipidation etc) to improve in vivo half-life. Finally B7-33 and stabilised analogs will be tested in clinically relevant experimental models of cardiac fibrosis to confirm their potential for translation as an anti-fibrotic agent.

Research team

Research group


Professor Chrishan Samuel
Professor Ross Bathgate

Take part in this project

Student applications

Students who are applying to study at The Florey can register their interest in this project. Refer to our step-by-step guide to help you with your application.

How to apply

Accepting students

Contact us

Professor Akhter Hossain

[email protected]